dendritic cell vaccine increases breadth diversity melanoma neoantigen-specific t cells
t cell immunity directed tumor-encoded amino acid substitutions occurs melanoma patients implicates missense mutations source patient-specific neoantigens however systematic evaluation putative neoantigens targets antitumor immunity lacking moreover remains unknown whether vaccination can augment responses found dendritic cell vaccine led increase naturally occurring neoantigen-specific immunity revealed previously undetected human leukocyte antigen hla class i-restricted neoantigens patients advanced melanoma presentation neoantigens hla-a* : human melanoma confirmed mass spectrometry vaccination promoted diverse neoantigen-specific t cell receptor tcr repertoire terms tcr-beta usage clonal composition results demonstrate vaccination directed tumor-encoded amino acid substitutions broadens antigenic breadth clonal diversity antitumor immunity
